CEA is discussed as a potential tumour marker for carcinomas of the urothel
ium. However, investigations by means of polyclonal antibodies have shown v
arious cross reactions which are not to be expected with monoclonal antibod
ies (MAb). Immunohistochemistry was done with the MAb anti-CEA BW 431/26 (B
ehring), N 1522 (Dako), and C 7292 (Sigma) on 37 carcinomas of the urotheli
um (grades 1-3). The MAb BW 431/26 showed the best results concerning speci
fity and sensitivity. In general, immunohistological investigations demonst
rated negative or moderate staining reactions. Positive reactions were seen
in 32 % (12/37) of the carcinomas. Staining intensity for CEA correlated w
ith differentiation grade. On the whole, a maximum of 5 % of the tumour cel
ls were CEA positive. Our results indicate that monoclonal anti-CEA antibod
ies are not usefull as a tumour marker for urothelial carcinomas. For the s
uitability of CEA for in vitro and for in vivo diagnosis a threshold of CEA
positive tumour cells has to be defined.